Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcutaneous Spinal Neuromodulation to Normalize Autonomic Phenotypes

NCT04858178 is registered in ClinicalTrials.gov with Spaulding Rehabilitation Hospital as lead sponsor.

NCT NCT04858178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcutaneous Spinal Neuromodulation to Normalize Autonomic Phenotypes
Lead sponsor
Spaulding Rehabilitation Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 17, 2022
Completion date
November 14, 2022
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autonomic dysreflexia, autonomic imbalance, orthostatic; hypotension, neurogenic, spinal cord injuries